For more than 25 years, lab-on-a-chip technology has allowed researchers to model human organs and blood vessels using real ...

(NASDAQ: ILMN) today announced that the Billion Cell Atlas alliance has added three new member companies, including AI-native drug developer Formation Bio. As leaders in AI-driven drug discovery, ...

Neurons in the brains of Alzheimer’s patients are being destroyed from the inside before the disease’s signature plaques ever ...

Coded cells are changing how modern day researchers develop drugs, for the benefit of the STEM space and society.

A new study challenges a 60-year-old assumption about the body’s main structural building block, opening new possibilities ...

Early in the progression of Alzheimer's and other neurodegenerative diseases, DNA inside neurons starts showing signs of ...

Gross SC-islet morphology and size were maintained, yet the fraction of NKX6.1-positive β cells fell substantially, pointing ...

Memory is foundational to our human experience. By tracking and storing our experiences, it helps us navigate the world and ...

ALS is linked to toxic TDP-43 protein clumps. A new strategy targets a specific protein region. A small molecule, XL20, prevents clumping, reducing nerve damage in human cells. XL20 extended survival ...

Future therapies for respiratory syncytial virus (RSV) must target both the virus and the immune response to ensure babies ...

A drug that has passed phase 1 trials for spinal injuries in people repaired DNA breaks and reduced inflammation in mouse ...